| Date Filed | Type | Description |
| 07/24/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 07/20/2023 |
3
| Form 3 - Initial statement of beneficial ownership of securities: |
| 05/19/2023 |
4
| Gupta Rishi (10% Owner) has filed a Form 4 on Enliven Therapeutics, Inc.|
Txns:
| Exercised 2,125 options to buy
@ $4.28, valued at
$9.1k
|
|
| 05/15/2023 |
4
| Gupta Rishi (Director) has filed a Form 4 on Verona Pharma plc|
Txns:
| Sold 80,000 shares
@ $22.26, valued at
$1.8M
Sold 43,200 shares
@ $21.64, valued at
$934.8k
Sold 14,400 shares
@ $21.96, valued at
$316.2k
Sold 345,313 shares
@ $20, valued at
$6.9M
|
|
| 04/28/2023 |
4
| Gupta Rishi (Director) has filed a Form 4 on Verona Pharma plc|
Txns:
| Granted 96,000 options to buy
@ $0 |
|
| 02/27/2023 |
4
| Gupta Rishi (10% Owner) has filed a Form 4 on Enliven Therapeutics, Inc.|
Txns:
| Granted 7,611,458 shares
@ $0
Granted 288,114 shares
@ $0 |
|
| 02/27/2023 |
3
| Gupta Rishi (10% Owner) has filed a Form 3 on Enliven Therapeutics, Inc. |
| 04/29/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 08/10/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 01/05/2021 |
3
| Form 3 - Initial statement of beneficial ownership of securities: |
| 01/04/2021 |
3
| Form 3 - Initial statement of beneficial ownership of securities: |
| 05/23/2016 |
4
| Gupta Rishi (Director) has filed a Form 4 on Dimension Therapeutics, Inc.|
Txns:
| Granted 32,069 options to buy
@ $7.08, valued at
$227k
|
|
| 10/29/2015 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 06/26/2012 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |